Jupiter Asset Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-256,347
Closed -$23.7M 430
2024
Q2
$23.7M Buy
256,347
+253,437
+8,709% +$22.4M 0.22% 142
2024
Q1
$278K Sell
2,910
-427,300
-99% -$35.9M ﹤0.01% 407
2023
Q4
$32.8M Sell
430,210
-372,036
-46% -$25.9M 0.33% 94
2023
Q3
$55.6M Buy
802,246
+661,374
+469% +$53.1M 0.62% 36
2023
Q2
$13.3M Sell
140,872
-16,855
-11% -$1.46M 0.15% 181
2023
Q1
$13M Sell
157,727
-511,464
-76% -$40.2M 0.18% 160
2022
Q4
$49.9M Buy
669,191
+28,938
+5% +$2.23M 0.73% 27
2022
Q3
$52.9M Sell
640,253
-3,539
-0.5% -$341K 0.82% 25
2022
Q2
$61.3M Buy
643,792
+22,846
+4% +$2.37M 0.86% 17
2022
Q1
$73.1M Buy
620,946
+132,841
+27% +$14.9M 0.87% 18
2021
Q4
$63.8M Buy
488,105
+4,774
+1% +$557K 0.7% 26
2021
Q3
$54.7M Buy
483,331
+44,934
+10% +$5.13M 0.62% 35
2021
Q2
$45.4M Sell
438,397
-126,763
-22% -$11.9M 0.47% 56
2021
Q1
$47.3M Sell
565,160
-294,117
-34% -$24.9M 0.46% 57
2020
Q4
$78.4M Sell
859,277
-114,936
-12% -$9.53M 0.79% 19
2020
Q3
$77.7M Buy
974,213
+969,077
+18,868% +$75.6M 0.82% 21
2020
Q2
$355K Buy
+5,136
New +$365K 0.01% 255

Other funds holding EW

Jupiter Asset Management's EW Position: Q3 2024 in Review

Jupiter Asset Management sold out of Edwards Lifesciences (EW) in Q3 2024, closing a stake of 256,347 shares — an estimated $23.7M sold.

Jupiter Asset Management first reported a position in EW in Q2 2020 and held it in 17 quarters. The position peaked at $78.4M in Q4 2020. 1,194 funds tracked by Wall St. Rank hold EW as of Q3 2024.

  • Jupiter Asset Management reported no remaining Edwards Lifesciences position as of Q3 2024 after selling out during the quarter.
  • Jupiter Asset Management sold 256,347 Edwards Lifesciences shares in Q3 2024, an estimated $23.7M.
  • Jupiter Asset Management first reported a position in Edwards Lifesciences in Q2 2020 and held it in 17 quarters.
  • Jupiter Asset Management's Edwards Lifesciences position peaked at $78.4M in Q4 2020.
  • 1,194 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2024.

Based on Jupiter Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.